Skip to content

Author

Marina Romozzi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Development of a machine learning (ML) model to predict 3-month response to CGRP monoclonal antibodies in migraine: A pilot evaluation of physician-ML model interaction.

BACKGROUND Predicting individual treatment responses to anti-calcitonin gene-related peptide monoclonal antibodies (CGRP-mAbs) in migraine remains challenging. OBJECTIVE To develop a machine learning (ML) model for predicting 3-month treatment response to CGRP-mAbs and to evaluate its practical clinical utility in im...

Masahito Katsuki, M. Tatsumoto, Tomokazu Shimazu et al. · 0 citations
Review Open access Oct 2026

Preliminary evidence of long‐term safety and effectiveness of anti‐CGRP drugs for migraine prevention in people with comorbid epilepsy: A 52‐week follow‐up retrospective study

Abstract Migraine and epilepsy frequently coexist, but evidence on the safety of calcitonin gene‐related peptide (CGRP)‐targeting therapies in people with epilepsy is lacking. We evaluated long‐term migraine and epilepsy outcomes in a real‐world multicenter retrospective cohort of adults with comorbid migraine and epil...

Marina Romozzi, Andrea Burgalassi, Francesco Ceriello et al. · 0 citations
Open access Sep 2026

New-onset cervical pain followed by ophthalmoplegia revealing cavernous sinus meningioma

Background: Headache and facial pain may occur in patients with meningioma, but their diagnostic significance is often underestimated when pain resembles a primary headache phenotype or occurs in a patient with a long-standing history of tension-type headache. Cavernous sinus meningiomas are particularly relevant in he...

Matteo Palermo, Marina Romozzi, Vittoria Viglione et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.